IL20RB and chronic obstructive pulmonary disease: Therefore, we need to better understand the mechanisms underlying the beneficial effects of the treatment using anti-IL-20Rb antibody on tissue damages, and we need to check if anti-IL-20Rb antibody could limit pulmonary viral infections not only with RSV but also with another important cause of AE-COPD, the influenza A virus.